WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016090168) COMPOSITIONS AND METHODS OF USING MODIFIED RELEASE SOLABEGRON FOR LOWER URINARY TRACT SYMPTOMS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/090168    International Application No.:    PCT/US2015/063795
Publication Date: 09.06.2016 International Filing Date: 03.12.2015
IPC:
A61K 31/135 (2006.01)
Applicants: VELICEPT THERAPEUTICS, INC. [US/US]; 101 Lindenwood Drive Suite 400 Malvern, Pennsylvania 19355 (US)
Inventors: OHLSTEIN, Eliot; (US).
STEVENS, Raymond, E.; (US).
WILKINS, H., Jeffrey; (US)
Agent: STAKLEFF, N., Nicole; (US)
Priority Data:
62/087,021 03.12.2014 US
Title (EN) COMPOSITIONS AND METHODS OF USING MODIFIED RELEASE SOLABEGRON FOR LOWER URINARY TRACT SYMPTOMS
(FR) COMPOSITIONS ET PROCÉDÉS D'UTILISATION DU SOLABÉGRON À LIBÉRATION MODIFIÉE POUR TRAITER DES SYMPTÔMES DU BAS APPAREIL URINAIRE
Abstract: front page image
(EN)This application relates to pharmaceutical compositions, comprising solabegron that are useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to methods for treating lower urinary tract symptoms utilizing the pharmaceutical compositions, comprising solabegron. In some embodiments, the pharmaceutical compositions, comprising solabegron comprise a dual release drug delivery system.
(FR)La présente invention concerne des compositions pharmaceutiques comprenant du solabégron, qui sont utiles pour le traitement de symptômes du bas appareil urinaire tels que, par exemple, une vessie hyperactive et des troubles de la prostate. De plus, la présente invention concerne des méthodes de traitement des symptômes du bas appareil urinaire ay moyen des compositions pharmaceutiques comprenant du solabégron. Dans certains modes de réalisation, les compositions pharmaceutiques, contenant du solabégron, comprennent un système d'administration de médicament à libération double.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)